Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 168, Issue 1, pp 113–117 | Cite as

Structural and Functional Bases of Genitourinary Syndrome of Menopause

  • A. K. PichiginaEmail author
  • N. V. Shelkovnikova
  • A. I. Neimark
  • G. A. Lapii
MORPHOLOGY AND PATHOMORPHOLOGY
Part of the following topical collections:
  1. Topical Collection on Gun Violence

We performed a comprehensive clinical and morphological examination of 70 menopausal patients aged 42-62 years with dysuria and chronic pelvic pain. Assessment of the bladder and vaginal microcirculation by laser Doppler flowmetry in menopausal patients with genitourinary syndrome revealed reduced (by 12-65%) microcirculation parameters. Analysis of the quantitative and qualitative composition of the bacterial microflora of the urethra and vagina revealed abnormalities of microbiota of varying severity, which can be the cause of infectiousinflammatory processes in the pelvic organs leading to chronic pelvic pain syndrome and incontinence. During menopause, the genitourinary syndrome in women is associated with the combined development of atrophic changes in the bladder and uterine mucosa that by their morphological characteristics differ from age-related involutive changes. Atrophy (hypoplasia) of the endometrium and bladder mucosa develops against the background of pronounced fibrosis and is accompanied by hyperemia and hemorrhages.

Key Words

genitourinary syndrome menopause opportunistic microflora morphology laser Doppler flowmetry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Balan VE, Kovaleva LA. Urogenital syndrome in menopause: therapy possibilities. Akush. Gin. 2015;(5):104-108. Russian.Google Scholar
  2. 2.
    Neimark AI, Kondrat’eva YuS, Neimark BA. Laser Doppler Flowmetry in Diseases of Urogenital System. Moscow, 2011. Russian.Google Scholar
  3. 3.
    Smetnik VP. Genitourinary syndrome of menopause: The new term, rationale, and discussion. Akush. Gin. 2016;(4):7-10. Russian.Google Scholar
  4. 4.
    Yureneva SV, Glazunova AV, Yeprikyan YG, Donnikov AE, Yezhova LS. Therapy for vulvovaginal atrophy in postmenopausal women: clinical and pathogenetic aspects. Akush. Gin. 2017;(6):143-150. Russian.Google Scholar
  5. 5.
    Bani-Irshaid I, Al-Sumadi A. Histological findings in women with postmenopausal bleeding: Jordanian figures. East. Mediterr. Health J. 2011;17(7):582-586.CrossRefGoogle Scholar
  6. 6.
    Biglia N, Bounous VE, D’Alonzo M, Ottino L, Tuninetti V, Robba E, Perrone T. Vaginal atrophy in breast cancer survivors: Attitude and approaches among oncologists. Clin. Breast Cancer. 2017;17(8):611-617.CrossRefGoogle Scholar
  7. 7.
    Deeba F, Shaista, Khan B. Histological pattern of endometrial samples in postmenopausal women with abnormal uterine bleeding. J. Ayub Med. Coll. Abbottabad. 2016;28(4):721-724.Google Scholar
  8. 8.
    Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: Management strategies for the clinician. Mayo Clin. Proc. 2017;92(12):1842-1849.CrossRefGoogle Scholar
  9. 9.
    Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am. J. Obstet. Gynecol. 2016;215(6):704-711.CrossRefGoogle Scholar
  10. 10.
    Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst. Rev. 2016;31(8). ID CD001500. doi: 10.1002/14651858. CD001500.pub3Google Scholar
  11. 11.
    Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50.CrossRefGoogle Scholar
  12. 12.
    Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Kirkland JL, LeBrasseur NK, Schafer MJ, Mielke MM, Kantarci K, Stewart EA, Miller VM. Loss of ovarian hormones and accelerated somatic and mental aging. Physiology (Bethesda). 2018;33(6):374-383.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Santoro N, Worsley R, Miller KK, Parish SJ, Davis SR. Role of estrogens and estrogen-like compounds in female sexual function and dysfunction. J. Sex. Med. 2016;13(3):305-316.CrossRefGoogle Scholar
  14. 14.
    Vieira-Baptista P, Marchitelli C, Haefner HK, Donders G, Pérez-López F. Deconstructing the genitourinary syndrome ofmenopause. Int. Urogynecol. J. 2017;28(5):675-679.CrossRefGoogle Scholar
  15. 15.
    Zhang D, Li J, Xu G, Zhang R, Zhou C, Qian Y, Liu Y, Chen L, Zhu B, Ye X, Qu F, Liu X, Shi S, Yang W, Sheng J, Huang H. Follicle-stimulating hormone promotes age-related endometrial atrophy through cross-talk with transforming growth factor beta signal transduction pathway. Aging Cell. 2015;14(2):284-287.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • A. K. Pichigina
    • 1
    Email author
  • N. V. Shelkovnikova
    • 2
  • A. I. Neimark
    • 2
  • G. A. Lapii
    • 1
  1. 1.Institute of Molecular Pathology and PathomorphologyFederal Research Center for Fundamental and Translational MedicineNovosibirskRussia
  2. 2.Altai State Medical UniversityBarnaulRussia

Personalised recommendations